DeepMed Research

Uthealth Houston

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1967-01-01

Employees: 11

Market Cap: -

Website: https://www.cizikeyedoctors.org

Clinical Trials

Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea in Non-HIV Patients

Phase 4

Completed

Conditions: Chronic Diarrhea of Unknown Origin

Interventions: Drug: Crofelemer
Diagnostic Test: Diagnostic tests for cause of chronic diarrhea

First Posted Date: 2019-04-02

Last Posted Date: 2025-02-12

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 93

Registration Number: NCT03898856

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients

Phase 4

Completed

Conditions: Pediatrics
Anesthesia
Vasospasm

Interventions: Drug: Papaverine
Drug: Rescue papaverine, as needed
Drug: Heparin

First Posted Date: 2019-03-29

Last Posted Date: 2022-10-27

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 100

Registration Number: NCT03894904

Locations: 🇺🇸
UT Health, Houston, Texas, United States

Modifying a Telephone Based Care Program to Assess for Self-Neglect

Not Applicable

Conditions: Self Neglect

Interventions: Behavioral: Benjamin Rose Institute Care Consultation (BRI-CC)

First Posted Date: 2019-03-21

Last Posted Date: 2019-03-21

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 60

Registration Number: NCT03885063

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest

Not Applicable

Withdrawn

Conditions: Head and Neck Neoplasms
Dysesthesia

Interventions: Device: Collagen Nerve Wrap Conduit

First Posted Date: 2019-03-15

Last Posted Date: 2023-05-22

Lead Sponsor: The University of Texas Health Science Center, Houston

Registration Number: NCT03875833

Resveratrol Trial for Relief of Pain in Pseudoachondroplasia

Phase 2

Terminated

Conditions: Pseudoachondroplasia

Interventions: Drug: resveratrol
Drug: Placebo

First Posted Date: 2019-03-07

Last Posted Date: 2022-12-09

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 6

Registration Number: NCT03866200

Locations: 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States

Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)

Phase 1

Terminated

Conditions: Alcohol Use Disorder

Interventions: Drug: Pioglitazone
Drug: Placebo

First Posted Date: 2019-03-04

Last Posted Date: 2020-10-26

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 4

Registration Number: NCT03860753

Locations: 🇺🇸
The University of Texas Health Science at Houston, Houston, Texas, United States

Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care

Not Applicable

Terminated

Conditions: Fetal Growth Abnormality
Amniotic Fluid; Disorder

Interventions: Diagnostic Test: Point-of-care ultrasound (POC-US)
Diagnostic Test: Routine antenatal care
Diagnostic Test: Formal ultrasound

First Posted Date: 2019-02-28

Last Posted Date: 2021-06-10

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 113

Registration Number: NCT03857659

Locations: 🇺🇸
University of Texas Health Science Center of Houston, Houston, Texas, United States

The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns

Phase 4

Completed

Conditions: Prematurity

Interventions: Drug: Intralipid, 20% Intravenous Emulsion
Drug: Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid

First Posted Date: 2019-02-28

Last Posted Date: 2025-03-03

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 66

Registration Number: NCT03857646

Locations: 🇺🇸
University Texas Houston HSC, Houston, Texas, United States

Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease

Phase 3

Completed

Conditions: Huntington Disease
Irritability

Interventions: Drug: Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)
Drug: Placebo

First Posted Date: 2019-02-26

Last Posted Date: 2024-01-05

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 20

Registration Number: NCT03854019

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).

Not Applicable

Conditions: Non-Alcoholic Fatty Liver Disease

Interventions: Behavioral: Modified Time-restricted Feeding
Behavioral: Conventional diet
Behavioral: Physical activity
Behavioral: Restricted consumption of sweetened beverages

First Posted Date: 2019-02-20

Last Posted Date: 2019-03-15

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 40

Registration Number: NCT03848390

Locations: 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy